David Abrams · Q4 2015
Abrams Capital Management
Portfolio at the end of Q4 2015, from the 13F filed February 12, 2016. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| Western Union WU · history | 21.2% | Q2 2013 or earlier | No change |
| Microsoft MSFT · history | 15.1% | Q1 2014 | No change |
| Franklin Resources BEN · history | 10.6% | Q4 2015 | Buy |
| Wells Fargo WFC · history | 8.2% | Q4 2013 | No change |
| Cleco CNL · history | 6.7% | Q3 2015 | Add 97% |
| Time Warner Cable TWC · history | 6.7% | Q4 2015 | Buy |
| Manitowoc MTW · history | 6.1% | Q3 2015 | Add 44% |
| Barnes & Noble Education BNED · history | 4.5% | Q3 2015 | Add 15% |
| Interxion INXN · history | 3.9% | Q3 2014 | No change |
| Barnes & Noble BKS · history | 3.5% | Q1 2014 | Add 7% |
| VEON VEON · history | 3.3% | Q1 2015 | Add 78% |
| Opus Bank OPB · history | 3.2% | Q2 2014 | Reduce 22% |
| Global Eagle Entertainment ENT · history | 2.7% | Q4 2013 | No change |
| MoneyGram MGI · history | 1.8% | Q4 2014 | No change |
| Keryx Biopharmaceuticals KERX · history | 1.5% | Q3 2015 | Add 10% |
| Clear Channel Outdoor CCO · history | 1.0% | Q2 2013 or earlier | No change |
| 16 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q3 2015, adjusted for stock splits.
Sector weighting
| Financials & real estate | 45.0% | |
|---|---|---|
| Technology | 19.0% | |
| Media & telecom | 13.7% | |
| Consumer discretionary | 8.0% | |
| Utilities | 6.7% | |
| Industrials | 6.1% | |
| Health care | 1.5% |
What changed from Q3 2015
- Buy Franklin Resources BEN 10.6% of the 13F
- Buy Time Warner Cable TWC 6.7% of the 13F
- Add 97% Cleco CNL 4.6% → 6.7%
- Add 44% Manitowoc MTW 5.4% → 6.1%
- Add 15% Barnes & Noble Education BNED 6.5% → 4.5%
- Add 7% Barnes & Noble BKS 6.0% → 3.5%
- Add 78% VEON VEON 3.0% → 3.3%
- Add 10% Keryx Biopharmaceuticals KERX 1.3% → 1.5%
- Reduce 22% Opus Bank OPB 5.6% → 3.2%